I listened to the webcast and was not especially impressed. They really have no plan to make Aggrastat a commercial hit in the U.S. It sells well abroad, but that’s only because it’s cheap.
I wanted to hear about MCU’s preclinical thrombin and platelet inhibitor, but they didn’t have time to cover it.
Market Data 
Markets 
AI
